Back to today’s briefing

Story perspectives

Weight-Loss Medications Could Boost U.S. GDP by 3%

2/25/2025

34 3

Summary

Story summary

Weight-loss medications like Ozempic and Wegovy could be game-changers for the U.S. economy, with Goldman Sachs projecting a GDP surge of 0.4-3% by 2028 if 60 million people adopt these treatments. Enhanced health may foster a more productive workforce, reshaping consumer habits and revitalizing multiple industries.

1 of 1

Story summary

Weight-loss medications like Ozempic and Wegovy could be game-changers for the U.S. economy, with Goldman Sachs projecting a GDP surge of 0.4-3% by 2028 if 60 million people adopt these treatments. Enhanced health may foster a more productive workforce, reshaping consumer habits and revitalizing multiple industries.